Our cohort of early-onset PD patients all had testing for pathogenic variants in LRRK2 and GBA, but they did not all undergo thorough investigation for pathogenic variants in other genes, and therefore these results should be interpreted with caution. The gene discussed is LRRK2; the disease is Parkinson disease.